🔴 Park Ha Biological Technology is trading 8.39% down in pre-market; immediate catalyst unconfirmed

Park Ha Biological Technology is trading at $2.95, down 8.39%, after closing at $3.22 on August 6 following an 875.46% split-adjusted surge; the immediate catalyst remains unconfirmed.

• The 1-for-8 reverse split became effective August 6, with split-adjusted trading beginning that session.
• Robbins LLP announced a securities class action alleging market manipulation and inadequate risk disclosures.
• No announcement explicitly ties either event to the August 7 pre-market decline.